Observational studyCancer medicine2026

Dacomitinib as a First-Line Therapy for Advanced EGFR-Mutated Non-Small Cell Lung Cancer Without Brain Metastases: A Multicenter Retrospective Observational Study.

Ping-Chih Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.